NASDAQ
GAITHERSBURG, Md.--(BUSINESS WIRE)--The GUARDIAN study has been recognized as one of the most impactful scientific contributions published across all JAMA journals this year....
Cim LLC bought a new position in GeneDx Holdings Corp. (NASDAQ: WGS) during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 4,770 shares of the...
GeneDx Holdings Corp. (NASDAQ: WGS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eleven brokerages that are covering the company, Marketbeat reports. One analyst has rate...
Ardsley Advisory Partners LP purchased a new position in shares of GeneDx Holdings Corp. (NASDAQ: WGS) in the second quarter, according to its most recent filing with the SEC. The firm purchased 80,00...
GeneDX provides an artificial intelligence-powered genetic testing platform. CEO Katherine Stueland sold about $300,000 worth of shares on Oct. 29....
Cathie Wood shifted several positions across her ARK ETFs on Dec. 4, moving money out of two Mega tech names and into mid-cap growth stocks.ARK sold 14,211 shar...
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Nov. 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inves...
Sold 69,858 shares, reducing stake value by about $6.45 million Post-trade stake in GeneDx Holdings Corp: zero shares, $0 value The position previously comprised 1.9% of the fund's AUM as of the prior...
Added 120,000 shares of GeneDx Holdings, an increase valued at ~$12.93 million Post-trade stake: 120,000 shares worth $12.93 million as of September 30, 2025 GeneDx Holdings is not among Telemark Asse...
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx announced it will unveil research findings during four key sessions at the 2025 National Society of Genetic Counselors (NSGC) Annual Meeting....
No price data available for this timeframe.